Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter decongestants – from the market, citing evidence that it doesn’t work.
FDA to pull common but ineffective cold medicine from market
The
FDA
's proposal comes more than a year after the agency's outside advisers voted against continued use of the ingredient, called oral phenylephrine, citing concerns with the initial data used to support its approval and new data questioning its ...
FDA says commonly used decongestant 'not effective,' proposes removal
The U.S. Food and Drug Administration has determined commonly used oral phenylephrine is "not effective" and has proposed its removal from over-the-counter nasal decongestants. "It is the FDA's role to ensure that drugs are safe and effective,
FDA wants to remove popular decongestants from stores permanently that contain this ingredient
DAYTON — The Food and Drug Administration says it wants to remove some of the most popular over-the-counter decongestants that have a common ingredient in them. The FDA said there’s evidence that phenylephrine doesn’t work. Brand names like Sudafed, DayQuil and others contain the ingredient, our sister station WSB-TV reported.
U.S. FDA proposes ending use of popular decongestant present in cold medicines
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective,
FDA proposes ending use of decongestant found in many cold, allergy medicines
An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.
FDA moves to pull popular cold and flu medicines from shelves
The FDA is proposing many popular over-the-counter cold and allergy medications be removed from store shelves. The agency says a common ingredient they share, phenylephrine, doesn’t actually relieve nasal congestion.
FDA proposes removing ineffective decongestant found in most cold medicine
The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral over-the-counter cold medicines because it doesn’t work.
FDA considers pulling some cold medicine
FDA considers pulling some cold medicine
FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine
More than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal congestion, the U.S. Food and Drug Administration is proposing that it be removed from common over-the-counter decongestants.
CBC Online 1380 KCIM
3h
FDA seeks to pull common but ineffective OTC cold medicine ingredient off the market
The Food and Drug Administration (“FDA”) said on Thursday that they will seek to pull the common ingredient phenylephrine off ...
17h
on MSN
FDA Wants to Ban Popular but Ineffective Cold Remedy Ingredient
U.S. health officials proposed banning an ingredient used in popular oral decongestants, a step toward removing dozens of ...
STAT
17h
How a Trump presidency could affect the FDA, the biotech industry, and its stocks
STAT's Readout LOUD podcast discusses how Trump's second term and the MAHA movement could affect FDA regulation, the ...
19h
on MSN
RFK Jr warns he plans on clearing out entire departments of the FDA
Robert F Kennedy Jr, a likely political appointee in Trump’s new government, has already announced his intentions to clear ...
2h
on MSN
Texas Butter Recall Update as FDA Sets Risk Level
On Thursday, November 7, the FDA categorized this recall as a Class II, meaning: "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse ...
21h
US FDA approves Johnson & Johnson's device for heart condition
The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...
Fortune on MSN
21h
RFK Jr. is expected to join Trump’s government after warning the ‘FDA’s war on public health is about to end,’ telling all employees to ‘pack your bags’
Kennedy Jr. has been a vaccine skeptic, sometimes a conspiracy theorist, and he might just be a part of president-elect ...
STAT
1d
D.C. Diagnosis: RFK Jr. targets the F in FDA
Big changes could be coming to the
FDA
under a Trump administration. On Wednesday, RFK Jr. suggested he’d fire officials in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Donald Trump
RFK Jr
Food and Drug Administration
COVID
sotagliflozin
Feedback